Use of Klexan drug for preventing thrombembolia in spinal surgery

Authors

  • Volodymyr Radchenko
  • Vladyslav Tuliakov
  • Oleksandr Levshin
  • Oleksandr Sirenko

DOI:

https://doi.org/10.15674/0030-59872011290-93

Keywords:

anticoagulant, klexan, prevention of thromboembolism

Abstract

The article describes experience of using Klexan drug, manufactured by SANOFI AVENTIS Company, with preventive daily doses of 40 mg in the surgical practice of the Vertebrology Department of the Institute, where 414 patients were operated in 2009. Results of the study showed higher values of excellent and good results and a reduction of unsatisfactory ones.

References

  1. Баркаган З.С. Диагностика и контролируемая терапия нарушений гемостаза / З.С. Баркаган, А.П. Момот. — М.: Ньюдиамед-АО, 2001. — 296 с.
  2. Гланц С. Медико-биологическая статистика: пер. с англ. / С. Гланц. − М.: Практика, 1998. − 459 с.
  3. Момот А.П. Патология гемостаза. Принципы и алгоритмы клинико-лабораторной диагностики / А.П. Момот. — СПб.: ФормаТ, 2006. — 208 с.
  4. Момот А.П. К методике индивидуального контроля за достаточностью антикоагулянтной профилактики и терапии / А.П. Момот, З.С. Баркаган // Клин. лаб. диагностика. — 1999. — № 10. — С. 46–47. — ISSN 0869-2084.
  5. О значении мониторирования тромбинемии при профилактическом применении низкомолекулярного и нефракционного гепаринов у онкологических больных (предварительное сообщение) / А.Н. Шилова, С.А. Ходоренко, П.А. Воробьев и др. // Клин. фармакология и терапия. — 2002. — Т. 11, № 1. — С. 83–85.
  6. Hamilton M.G. Venous thromboembolism in neurosurgery and neurology patients. A Review. / M.G. Hamilton, R.D. Hull, G.F. Pineo // Neurosurgery. — 1994. — Vol. 34. — P. 280–296.
  7. Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism. European Society of Cardiology // Eur. Heart J. — 2000. — Vol. 21. — P. 1301–1336.
  8. Prevention of venous thrombosis and pulmonary embolism. NIH Consensus Development // JAMA. — 1986. — Vol. 256. — P. 744–749.
  9. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elektive hip surgery / A.G. Turpie, M.N. Levine, J. Hirsh et al. // N. Engl. J. Med. — 1986. — Vol. 315. — P. 925–929.

Downloads

How to Cite

Radchenko, V., Tuliakov, V., Levshin, O., & Sirenko, O. (2011). Use of Klexan drug for preventing thrombembolia in spinal surgery. ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS, (2), 90–93. https://doi.org/10.15674/0030-59872011290-93

Issue

No. 2 (2011)

Section

ORIGINAL ARTICLES

License

Copyright (c) 2014 Volodymyr Radchenko, Vladyslav Tuliakov, Oleksandr Levshin, Oleksandr Sirenko

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The authors retain the right of authorship of their manuscript and pass the journal the right of the first publication of this article, which automatically become available from the date of publication under the terms of Creative Commons Attribution License, which allows others to freely distribute the published manuscript with mandatory linking to authors of the original research and the first publication of this one in this journal.

Authors have the right to enter into a separate supplemental agreement on the additional non-exclusive distribution of manuscript in the form in which it was published by the journal (i.e. to put work in electronic storage of an institution or publish as a part of the book) while maintaining the reference to the first publication of the manuscript in this journal.

The editorial policy of the journal allows authors and encourages manuscript accommodation online (i.e. in storage of an institution or on the personal websites) as before submission of the manuscript to the editorial office, and during its editorial processing because it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the published manuscript citation (see The Effect of Open Access).